๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

p53 Mutation and overexpression in hepatocellular carcinoma and dysplastic nodules in the liver

โœ Scribed by Yun Kyung Kang; Chong Jai Kim; W. H. Kim; Hyun Ok Kim; Gyeong Hoon Kang; Y. I. Kim

Publisher
Springer
Year
1998
Tongue
English
Weight
419 KB
Volume
432
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

p53 Mutations and hepatitis B virus: Cof
p53 Mutations and hepatitis B virus: Cofactors in hepatocellular carcinoma
โœ Betty L. Slagle ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 421 KB

afflicted with both HCV and MC. Both Misiani et a1 and Lunel et be 'Ommended for their the mystery surrounding this fascinating group of patients. cryoglobulinemia patients: a randomized, crossover-controlled trial.

p21/WAF1, p53 and PCNA expression and p5
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
โœ Lan Fang Qin; Irene O. L. Ng; Sheung T. Fan; Matthew Ng ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 443 KB ๐Ÿ‘ 2 views

The cyclin-dependent kinase inhibitor p21/WAF1 is regulated by p53-dependent and p53-independent pathways. In addition, p21/WAF1 binds with proliferating cell nuclear antigen (PCNA) and inhibits the action of PCNA. To investigate the possible role of p21/WAF1 in human hepatocellular carcinomas (HCCs